Hollywood Hospital was a Vancouver center for LSD treatment whose dedicated alcoholism wing gave Al M. Hubbard a base for clinical work and discreet celebrity referrals. Its place in the history of psychedelic therapy lay not in a single proven cure, but in the practical network it helped sustain: treatment sessions, circulating expertise and supplies, and a model whose reported promise would be contested by more controlled trials elsewhere.

A Vancouver treatment center

By the late 1950s, Hubbard had persuaded Hollywood Hospital to devote an entire wing to treating alcoholics with LSD. He regularly conducted sessions there, making the hospital one of several Canadian facilities in which he pursued alcoholism treatment. The book reports impressive rates of success for Hubbard’s work, but gives no hospital-specific figures; those claims should not be mistaken for a quantified outcome established at this location.

The hospital belonged to a wider Canadian moment in which LSD therapy was gaining attention as a possible treatment for alcohol dependence. At Weyburn, Humphry Osmond and Abram Hoffer’s work had helped make the approach prominent, while clinicians elsewhere questioned whether the reported results would hold under stricter controls. Hollywood Hospital was one of the treatment sites in this expanding landscape, though the evidence does not identify it as the location of the Saskatchewan trials or their Toronto replication.

Hubbard’s sessions and referrals

Hubbard’s work made the hospital a destination as well as a treatment facility. He would fly from Vancouver to Los Angeles and discreetly bring Hollywood celebrities north for treatment. This sideline earned him the nickname Captain Trips, while his wider circuit connected the hospital to researchers and practitioners in several North American cities. At the hospital, that activity took institutional form in the dedicated wing and in Hubbard’s regular LSD sessions.

The arrangement also reflected a tension between treatment and commerce. LSD treatment for alcoholism using Hubbard’s method had become a business in Canada, and some institutions charged patients more than five hundred dollars for a session. Hubbard regarded profit from LSD as unethical, and the fees charged by institutions he worked with contributed to friction. He treated psychedelic therapy as philanthropy and spent down his fortune advancing it. Hollywood Hospital thus stood within a care system that could be both a clinical undertaking and a paid service, even when Hubbard himself resisted its commercial logic.

Clinical record and contested evidence

Hubbard’s name appears on one scientific paper, written with colleagues at Hollywood Hospital: “The Use of LSD-25 in the Treatment of Alcoholism and Other Psychiatric Problems,” published in 1961. The paper anchors the hospital’s association with the period’s clinical research, although the available account does not detail its methods or establish a separate result for the hospital’s patients.

The wider debate over LSD treatment shows why favorable reports and clinical effectiveness were not treated as interchangeable. In the early 1960s, the Addiction Research Foundation in Toronto attempted to replicate the Saskatchewan trials under more controlled conditions. Its clinicians used neutral rooms, limited interaction with volunteers, and, in some cases, restraints or blindfolds. The results did not match those reported by Osmond and Hoffer, and some volunteers had frightening experiences. The contrast sharpened a dispute over whether LSD treatment worked less well under rigorous control or whether the treatment depended on an engaged therapist and a supportive environment. Those Toronto procedures were not described as taking place at Hollywood Hospital; they form the broader evidentiary context in which the hospital’s treatment claims must be understood.

A node in a distributed practice

Hollywood Hospital’s historical significance comes from its combination of a fixed clinical setting and a mobile practitioner. The dedicated wing gave Hubbard a place to conduct treatment, while his travel carried clinical techniques and Sandoz LSD between centers. His activity at the hospital was therefore part of a distributed practice rather than an isolated institutional experiment. The hospital’s record preserves both the ambition of mid-century psychedelic treatment and the unresolved question at its center: how much of an apparent therapeutic effect belonged to the drug, and how much depended on the human and environmental conditions surrounding its use.